Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02365961 · ClinicalTrials.gov registry record · Phase 4
Hip Scope Fascia-iliaca (FI) Block Study
A Phase 4 study, sponsored by The Hawkins Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
NCT02365961 is a Phase 4 study that has completed, run by The Hawkins Foundation. The registered enrollment target is 84 participants.
The verdict
NCT02365961, a Phase 4 study, has completed, sponsored by The Hawkins Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
Study Summary
Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.
Interventions
- DRUG Epinephrine
- DRUG clonidine
- DRUG ropivicaine
- DRUG Noropin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02365961
The ClinicalTrials.gov registry entry for NCT02365961 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Hawkins Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Epinephrine is the first listed.
NCT02365961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02365961 about?
NCT02365961 is a clinical study titled "Hip Scope Fascia-iliaca (FI) Block Study". Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.
What is the current status of trial NCT02365961?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2015-04. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02365961?
The interventions under investigation include: Epinephrine (DRUG), clonidine (DRUG), ropivicaine (DRUG), Noropin (DRUG).
Who is sponsoring clinical trial NCT02365961?
This trial is sponsored by The Hawkins Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.